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Abstract: This paper characterizes in an in vitro setting the release of calcium (Ca) and phosphate 
(PO4) of 3D printed bioactive ceramic scaffold prepared from extrudable paste containing 
hydroxyapatite and β-tricalcium phosphate (β-TCP). Hydroxyapatite and β-TCP were calcined at 
800 ℃ for 11 h, fabricated into four experimental groups (100% HA, 100% β-TCP, 15%/85% 
HA/β-TCP, and 15%/85% HA/β-TCP (design)), sintered to 1100 ℃ for 4 h. Calcium and phosphorus 
concentrations were evaluated using ICP spectroscopy, and the release of Ca and PO4 ions during 
dissolution of the CaP-based scaffolds was measured by submerging in 0.05 mol/L 
Tris(hydroxymethyl)aminomethane-HCl and maintaining a temperature of 37 ℃. The Ca and PO4 
concentrations of the solutions were measured with the utilization of a calcium assay kit and a 
phosphate assay kit and read in a UV–visible spectrophotometer. The 100% HA scaffold group 
showed the greatest concentration of Ca ions (~1.9 mg/dL), but ultimately released at a lower amount 
as time increased; the 100% HA scaffold also showed the lowest total amount of calcium ions released 
over the course of evaluation. The results for the 100% β-TCP were on the opposite of the HA with 
the highest amount of calcium ion release over the study. While the PO4 ion release showed a similar 
trend as those observed with Ca ions with an apparent difference in the 100% HA scaffold group. 
There was nearly 0 mg/dL of the phosphate ions released in the first 24 h, in comparison to the 
amount of Ca ions released during the same time frame. Since various formulations can lead to 
different properties of these bioactive ceramic scaffolds, it is important to understand how the 
tailoring of this important biphasic material can impact the long-term outcome of an ever-important in 
vivo clinical trial in the future. 
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1  Introduction 
Bone wound healing is a complicated area of research, 
which has doctors, engineers, and scientists 
continuously searching for the most appropriate 
solutions. Currently there are no “ideal” options on the 
market to repair large, critical sized defects or load 
bearing areas. The future of bone grafting is leading 
towards the combination of materials and fabrication 
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processes, which will allow for fabrication of 
“tailor-able” devices. 
The repair of critical sized long bone defects is of 
special interest in the orthopedic field due to its 
reconstructive complexity. Much attention has been 
given to the defect site’s blood supply, with focus 
between bone and immune cells and mechanical 
reestablishment. Most commonly, the defects are 
caused by birth defect, trauma, or tumor resection. 
These issues may leave the patient with a critical sized 
defect, which must be controlled with suitable dead 
space management followed by bone reconstruction 
utilizing a grafting material or device, which is 
osteoconductive and degradable, while simultaneously 
minimizing complications and shortening the duration 
of recovery. 
Currently, the viable bone grafting material solution 
is calcium phosphate (CaP)-based, which possesses two 
(osteoconduction and osseointegration) of the 
following three properties: osteoconduction—the 
capability to support the growth of bone over its surface; 
osteogenesis—the process of extra cellular matrix 
deposition and subsequent mineralization by 
osteoblasts; and osseointegration—the ability to 
intimately interact with bone without an extra layer of 
soft tissue. However, different host-to-grafting material 
responses have been reported and should be taken into 
consideration while determining treatment options. 
The stability of calcium phosphate-based ceramics is 
known to be compositionally and structurally dependent 
[1], depending on the materials hydroxyapatite (HA), 
beta tri-calcium phosphate (β-TCP), or biphasic 
calcium phosphate (BCP). When these CaP-composed 
devices are implanted, the ceramic will undergo 
dissolution at different rates (HA < β-TCP < α-TCP) 
[2,3]. Additionally, when placed in vivo, the CaP 
ceramics induce a precipitation of a phase which is 
comparable to the HA-like mineral found in bone [4]. 
While in some instances it has been seen that a bone 
apatite-like material was formed in nonosseous sites 
[3,4]. Therefore, an important factor with regards to 
bioactivity (bone tissue formation rate and bone tissue 
bonding) is the release of ions from the dissolution of 
CaP ceramics, which in turn may affect cellular activity, 
organic matrix deposition, or mineral deposition [5,6]. 
There was an analysis and assessment of the 
dissolution of 3D printed lattice-based bioactive 
ceramic scaffolds (LBBCS) [7]. In an in vitro setting, it 
is of value to qualitatively and quantitatively analyze 
and observe any possible phase changes, which can 
possibly occur during the fabrication process or 
dissolution process [8,9]. In the past, there has been 
work done to try to interpret as well as predict the 
long-term effects of the dissolution of CaP ceramics. 
This study is set out to determine the relative 
dissolution behavior of four experimental groups (Table 
1) specifically the mean concentrations (mg/dL) of Ca 
and PO4 ions which were released from the 3D printed 
grafting devices in a Tris(hydroxymethyl) 
aminomethane-HCl buffer environment [4]. 
2  Materials and methods 
2. 1  Ink preparation 
Prior to 3D printing, the formulated colloidal gel was 
subjected to a series of powder processing steps at the 
beginning (e.g., calcining, attrition milling, and drying 
of the individual base materials), which is described in 
detail by Witek et al. [7]. The aforementioned 
processed ceramic powders were utilized for the 
colloidal ink suspension, with a solid volume fraction 
( solid ) of approximately 46% ceramics, (i.e., 100% HA 
(0.7 μm in particle size), 100% β-TCP (0.4 μm in 
particle size), or pre-determined ratio of HA:β-TCP) 
[10]. Upon calculating the appropriate amounts of 
ceramic powders, H2O, and dispersant, Darvan®821A 
(R.T. Vanderbilt Company, Inc., Norwalk, CT, USA), 
~15 mg/g of ceramic, the materials were added to a 
mixing container in which the bottom was charged with 
zirconia milling media (5 mm; Union Process, Akron, 
OH, USA). The mixture was spun in a conditioning 
mixer (THINKY AR-250; Thinky, Tokyo, Japan) for 
180 s at 2000 rpm. The next step was the addition of a 
thickening agent, Methylcellulose F4M (Dow Chemical 
Company, Midland, MI, USA), approximately 
8 mg/mL of ceramic, followed by spinning for ~120 s at 
2000 rpm. The final step was the addition of a gelling 
mechanism (polyethlyenimine (PEI); Sigma-Aldrich St. 
Louis, MO, USA). About 200 mg of polyethyleneimine  
per 30 mL of ink was added followed by spinning to 
achieve the desired consistency. 
After the colloidal gel was prepared, it was 3D 
printed into circular lattice scaffolds (Fig. 1). 
Table 1  Summary of the four primary experimental 
scaffold groups used for the in vitro dissolution evaluation 
of Ca and PO4 release over a set amount of time 
Group Description Abbreviation 
1 100% HA HA 
2 100% β-TCP β-TCP 
3 15%/85% HA/β-TCP BCP 
4 15%/85% HA/β-TCP(design) BCP (design) 




Fig. 1  Schematic of scaffold designed in RoboCAD 4.3 
(3D Inks, LLC Tulsa, OK, USA): (a) isometric view, (b) 
top view, (c) front/side view, and (d) final scaffold after 
sintering. 
2. 2  Sample fabrication 
The 3D direct-writing printer used a gantry robot with 
affixed syringe pumps to extrude the colloidal inks 
through a fine nozzle to build the 3D scaffold [11,12]. 
The 3D disc-shaped scaffolds (10 mm in diameter, 
~2 mm in thickness, 330 μm in struts, and 500 μm in 
pore size) were designed on a computer-aided design 
(CAD) software (RoboCAD 4.3, 3D Inks, LLC Tulsa, 
OK, USA) (Fig. 1). The 3D disc-shaped scaffolds were 
printed layer-by-layer at 10 mm/s deposition rate onto a 
flat ceramic substrate (ADS-96R, Coors Tek, Grand 
Junction, CO, USA) in low-viscosity paraffin oil 
(Ultra-Pure lamp oil, Lamplight Farms Inc., 
Menomonee Falls, WI, USA) to prevent drying of the 
structure during assembly. 
After the scaffolds were fabricated, they were 
removed from the oil bath and allowed to dry in air for 
~12 h prior to the sintering process. Heat treatment of 
the scaffolds was performed utilizing an electric furnace 
(Model LHT 02/17, Nabertherm GmbH, Lilienthal, 
Germany) to enhance the mechanical strength for 
handling during the experiments (e.g., in vitro 
dissolution study) [11]. During the sintering processing, 
the green body ceramics were densified and organic 
components were burned off. The firing protocol began 
by heating at 2 ℃/min until 400 ℃, dwelling at 400 ℃ 
for 2 h, then heating until 900 ℃ (~8 ℃/min), dwelling 
for 2 h at 900 ℃, heating at 3.3 ℃/min to ultimate 
temperature of 1100 ℃, dwelling at 1100 ℃ for 4 h, and 
finally cooling at ~8.0 ℃/min until the samples were 
cooled to room temperature (~30 ℃). The binder 
burnout during the sintering process resulted in a 
predictable volumetric shrinkage (~20%) and defects 
such as cracking and warping [10]. The sintering 
shrinkage of ceramics is an unavoidable step, and all 
dimensions of the designed geometric structure must be 
enlarged to account for this phenomena and to 
ultimately attain the final desired dimensions. 
2. 3  Chemical characterization 
Calcium (Ca) and phosphorus (P) concentrations were 
evaluated using inductively coupled plasma (ICP) 
spectroscopy (Thermo Jarell Ash, Trace Advantage, 
Franklin, MA, USA). For this objective, 10 mg of 
powders from each experimental group were dissolved 
in 35% HCl solution and mixed 100 mL of double 
distilled water in a volumetric flask. Suitable standard 
solutions for Ca (0, 20, and 40 ppm) and P (0, 10, and 
40 ppm) were prepared from 100 ppm standard 
solutions of the respective elements (Fisher Scientific, 
Pittsburgh, PA, USA). Each specimen in solution and 
standard solution was pumped through argon plasma, 
which was excited by a 2 kW, 27.12 MHz radio 
frequency generator [13]. Additionally scaffold groups 
were subjected to energy-dispersive X-ray spectroscopy 
(Hitachi S-4800, Schaumburg, IL, USA) for further 
verification of their respective Ca:P ratios. 
X-ray diffraction (XRD; Bruker AXS D8 Discover, 
Madison, WI, USA) was used to determine the 
crystalline phases present within the raw materials and 
experimental groups. Three different spectra from each 
testing group were obtained (n = 3 per group). The 
diffractometer was operated by using a curved crystal 
monochromator, operating at 45 mA and 45 kV, and 
scanned in 2θ range from 20° to 65° [7], with a step size 
of 0.02° at 3 s/step. 
Rietveld refinement analysis used the data collected 
from X-ray diffraction, and subsequently converted 
data to “.xy” format. The raw data was then input into 
Material Analysis Using Diffraction (MAUD) software 
for quantitative analysis. Rietveld analysis utilized the 
samples from previous XRD spectra (i.e., peak, height, 
width, and position). This refinement method was used 
to quantify the percentage of each phase (HA, β-TCP, 
and other commonly observed phases in calcium- and 
phosphate-based materials such as calcium oxide, CaO) 
present in different calcination temperatures and 
sintering groups. A least-squares fit approach was 
utilized to measured scans until replicating a theoretical 
scan (based on the structure in Inorganic Crystal 
Structure Data Base (ICSD)) [14,15]. The background, 
cell parameters, preferred orientation, peak asymmetry, 
atomic positions, site occupancy factors, and global 
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vibrational parameters were refined. 
The in vitro observation for the release of Ca and PO4 
ions during dissolution of the CaP-based scaffolds, was 
measured by submerging LBBCS in a 24 well plate 
(Corning® Costar®, Sigma-Aldrich, St. Louis, MO, 
USA) (n = 1 scaffold/well) containing 0.05 mol/L 
Tris(hydroxymethyl)aminomethane-HCl (bioWORLD, 
Dublin, OH, USA) solution with a pH of ~7.3 and 
maintaining a temperature of 37 ℃ (in an incubator). 
The weight of scaffold to volume of solution ratio was 
~1 mg/mL as recommended by Ducheyne et al. [4]. The 
time periods to be examined for the release of ions was 
from 1 h ranging to 2 weeks, with samples measured in 
triplicate for each time point. The Ca and PO4 
concentrations of the solutions were measured with the 
utilization of a calcium assay kit (QuantiChromTM 
Calcium Assay Kit (DICA-500), BioAssay Systems, 
Hayward, CA, USA) and a phosphate assay kit 
(Malachite Green Phosphate Assay Kit (POMG-25H), 
BioAssay Systems, Hayward, CA, USA), read in a 
UV–visible spectrophotometer (Cary 5000 UV-Vis-NIR, 
Santa Clara, CA, USA). 
2. 4  Statistical analysis 
For statistical evaluation, analysis of variance (ANOVA) 
at a 95% confidence interval by using IBM SPSS v23 
(IBM Corporation, Armonk, New York, USA) was 
utilized considering HA and β-TCP ratios as 
independent variables, thus Ca:P ratio and Ca and PO4 
ion concentrations were considered as dependent 
variables. 
3  Results 
The ICP results were used to verify the Ca:P ratio of the 
two individual materials, in each of the 3 experimental 
states: (i) raw (as received), (ii) after calcination 
(800 ℃), and (iii) post sintering (1100 ℃) (Fig. 2(a)). 
The trend in the β-TCP group shows an initial decrease 
from raw state to after calcination state, but then an 
increase in post sintering state. The Ca:P ratio slightly 
increases while going from raw, to calcined, and 
ultimately sintered state in the HA group. The one-way 
ANOVA statistical analysis results in p = 0.0204 and   
p = 0.022, for HA and β-TCP respectively, indicating 
significant effect due to the state of the material. 
Energy-dispersive X-ray spectroscopy (EDS) was 
completed to evaluate the Ca/P ratio for experimental 
scaffolds of 100% HA, 100% β-TCP, and 15%/85% 
HA/β-TCP. The Ca/P ratios observed for the different 
groups are similar to what is expected aside from 100% 
HA, which seems to be slightly on the lower end of the 
atomic value of ~1.67 (Fig. 2(b)). The EDS was done as 
a supplemental quantitative verification measurement 
on the primary sample groups. These values are taken as 
an estimate of final average of the groups. 
XRD spectra were collected of the individual raw 
materials for crystalline verification. Their spectra were 
matched to the theoretical HA and β-TCP. After 
confirmation of the materials was complete, and the 
experimental colloidal gels were fabricated and 
subjected to sintering at 1100 ℃, XRD spectra were 
obtained from the groups for crystalline phase 
determination and verification (Fig. 3(a)). The β-TCP 
phase is indicated by three high intensity peaks located 
   
Fig. 2  (a) Mean ± 95% confidence intervals for Ca/P ratio 
depicting the two primary groups (HA and β-TCP) and 
their state. (b) Mean ± 95% confidence intervals for Ca/P 
ratio of the experimental groups. 
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at 27.9°, 31.2°, and 34.4°, while the highest peaks for 
HA are 31.8° and 32.9° (Fig. 3(b)). High crystallinity is 
indicated by the narrow diffraction peaks described as 
sharp peaks. This result is in good agreement with other 
researchers’ works that found that biphasic mixing on a 
crystallite level is feasible [16–18]. 
The calcium (Ca) and phosphate (PO4) 
concentrations (mg/dL) of scaffold dissolution in 
Tris-HCl solution are summarized in Table 2. Figure 4 
indicates that the data, which begin at time point of 0 h 
to indicate the initial, are used for analysis of both 
calcium and phosphate. The 100% HA scaffold group 
shows the greatest concentration of Ca ions 
(~1.9 mg/dL), but ultimately releases at a lower amount, 
which can be seen at hour 336 (day 14). The 100% HA 
scaffold has the lowest amount of calcium ions released. 
On the other end of the materials, the 100% β-TCP has 
the highest concentration released with approximately a 
measurement of 7.6 mg/dL. The 15%/85% HA/β-TCP 
scaffold group falls in between the 100% HA and 100% 
β-TCP groups, and at day 14 has a Ca ion release of 
approximately 5.95 mg/dL. 
While the PO4 ion release shows a similar trend as 
that in Ca with one apparent difference in the 100% HA 
scaffold group. There is nearly 0 mg/dL of the 
phosphate ion released in the first 24 h, in comparison 
to the amount of Ca ions released during the same time 
frame. The 100% HA group eventually ends up having 
a release of approximately 5.1 mg/dL at day 14, but it is 
short of what the other three groups (100% β-TCP, 
15%/85% HA/β-TCP, and 15%/85% HA/β-TCP 
(design)) release in the same time period. 100% β-TCP, 
     
Fig. 3  (a) Percentage of each phase of the as-received raw materials prior to calcination (β-TCP vertical filled bars, calcium 
pyrophosphate (Ca Pyro) in hatched bars, and calcium oxide represented in horizontal filled bars). (b) The XRD spectra are a 
comparison between the two basic components of the ink. The upper box represents the XRD spectrum of hydroxyapatite (HA) 
group while the lower box represents the β-TCP group. A few of the most intense diffraction peaks are shown. 
Table 2  Ca and PO4 mean concentration as released from the mono- and bi-phasic scaffold groups; the standard 
deviations are noted in parentheses                                                              (Unit: mg/dL) 
Time (h) Group Element 
1 12 24 72 168 216 288 336 
1.864 1.971 2.015 3.874 2.463 3.659 4.540 4.469 Ca2+ (0.13) (0.24) (0.04) (0.05) (0.62) (0.48) (0.31) (0.04) 
0.079 0.089 0.108 0.952 2.112 2.284 3.882 5.112 
HA 
(PO4)3 (0.06) (0.09) (0.05) (0.00) (0.17) (0.04) (0.75) (0.59) 
1.485 2.015 2.256 5.250 5.675 6.129 7.349 7.632 Ca2+ (0.08) (0.31) (0.28) (0.76) (0.15) (0.31) (0.23) (0.65) 
1.304 1.636 1.939 4.265 7.183 7.525 7.912 7.912 
Monophasic 
β-TCP 
(PO4)3 (0.18) (0.14) (0.03) (0.44) (0.19) (1.59) (0.34) (1.01) 
1.044 1.318 1.606 3.601 4.245 4.621 5.510 5.947 Ca2+ (0.03) (0.08) (0.13) (0.38) (0.03) (0.62) (0.16) (0.16) 
1.099 1.788 2.367 4.659 6.685 8.097 8.496 8.581 
HA/β-TCP 
(PO4)3 (0.13) (0.23) (0.36) (1.29) (0.48) (0.06) (0.91) (0.34) 
0.770 0.914 1.215 2.555 3.465 3.426 4.038 4.437 Ca2+ (0.03) (0.04) (0.01) (0.03) (0.14) (0.26) (0.27) (0.16) 




(PO4)3 (0.05) (0.08) (0.26) (0.48) (0.57) (0.59) (0.72) (0.92) 
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15%/85% HA/β-TCP, and 15%/85% HA/β-TCP (design) 
follow the same trend, and at day 14, they all have an 
average PO4 ion concentration of ~8.61 mg/dL, with no 
significant difference between these three experimental 
scaffolds’ compositions. Additionally, the experimental 
scaffolds’ compositions were analyzed after the time in 
vitro, to verify no changes in phases. As seen in Figs. 
5(a)–5(d), when evaluating the relevant peaks, no 
differences are observed from time 0 thru 28 days, 
indicating that the material remains unaffected over 
time. 
4  Discussion and conclusions 
Being that a wide range of physical and chemical 
properties can be achieved with this particular bioactive 
ceramic by modifying specific parameters, such as the 
HA/β-TCP ratio, calcining and/or sintering temperature 
[19], these materials have been used to fabricate 
pre-formed implants and have shown considerably 
greater mechanical strength in comparison to other 
bioceramics used for similar bone grafting purposes 
[19]. The present study aimed to chemically 
characterize bioactive ceramic LBBCS prepared as 
100% HA, 100% β-TCP, 15%/85% HA/β-TCP, and a 
model 15%/85% HA/β-TCP group with raw materials 
calcined at 800 ℃, and final LBBCS subjected to a 
sintering regimen of 1100 ℃. 
The advantage of this material, which is fabricated to 
an aqueous paste, allows for fabrication of scaffolds 
utilizing solid free form (SFF) equipment also known as 
robocasting. This 3D printing technique allows for the 
production of variety of complex structures utilizing 
CAD/CAM software in addition to utilizing computed 
  
  
Fig. 4  (a) Ca concentration and (b) PO4 concentration in 
0.05 mol/L Tris buffer after immersion of 100% HA, 100% 
β-TCP, 15%/85% HA/β-TCP, and 15%/85% HA/β-TCP 
(design) for time periods ranging from 1 to 336 h (14 days). 
 
 
Fig. 5  These XRD spectra are for groups (a) 100% HA, 
(b) 100% β-TCP, (c) 15%/85% HA/β-TCP, and (d) 
15%/85% HA/β-TCP (design) and are a comparison among 
the six time points in vitro: (i) initial, (ii) 1 day, (iii) 7 days, 
(iv) 14 days, (v) 21 days, and (vi) 28 days. 
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tomography scans exported to a specific file type which 
can in turn be fabricated to a specific defect, capable of 
reproducing the same structure consistently [20]. 
XRD of the as-received materials prior to calcination 
primarily showed HA and β-TCP crystalline phases for 
the individual HA and β-TCP powders. However, phase 
quantification through Rietveld refinement showed 
trivial fractions of β-TCP, calcium pyrophosphate 
(Ca2P2O7), and calcium oxide (CaO) for the HA 
as-received material, and minor fractions of HA, 
Ca2P2O7, and CaO for the β-TCP starting material. 
Given that the aqueous pastes were fabricated without 
considering the presence of minor quantities of other 
CaP-based phases, the intended composition of the 
15%/85% HA/β-TCP group was slightly shifted from 
what was originally intended. 
Phosphorus (P) is widely distributed in the body.  
More than 80% of total phosphate (PO4) is present in 
the bone and teeth in the form of apatite. The remaining 
phosphate is mostly present in the skeletal muscle, with 
trace amounts in the extracellular fluids (< 0.1%) 
[21–24]. Intracellular phosphate ions are essential for 
oxidative phosphorylation and approximately 20% of 
cellular phosphate is present in the mitochondria. 
Roughly 30% of total cellular phosphate is stored in the 
endoplasmic reticulum and is used in phosphorylation 
of various proteins. The remaining cellular phosphate is 
present in the nucleus, Golgi complex, and lysosomes. 
Transporting phosphate in and out of the cell according 
to the need of the body is a complex process and the 
exact molecular mechanisms of such sensitive transport 
are not entirely clear. It is important to note that cells 
use PO4 to transport cellular energy through the 
formation of ATP by oxidative phosphorylation. 
With the aforementioned, phosphorus is an essential 
nutrient for the body and is routinely consumed through 
food. After consumption, phosphorus binds with 
oxygen and exists as PO4 in the body. Both organic and 
inorganic forms of PO4 are present in regularly 
consumed foods. The amount of total PO4 ingestion can 
be significantly influenced by consumption of 
processed food and beverage, as there are phosphate 
metabolites additives in these items. Following a meal, 
inorganic phosphate can be rapidly absorbed across the 
small intestine and enter the blood stream causing an 
elevation in blood phosphate levels. The net efficiency 
of intestinal phosphate absorption is double that of Ca 
[25]. Taking into consideration just the amount of 
phosphate consumed and adding a calcium phosphate 
(CaP)-based scaffold can lead to a potential toxic 
situation. Phosphate toxicity due to excessive retention 
of PO4 in the body can cause a variety of cellular and 
tissue damage. An example is seen with the higher 
occurrence of vascular calcification, encountered in 
patients with chronic kidney disease, is related to the 
increased retention of phosphate in the body [26,27]. 
The normal range of PO4 should be in the order of 
2.4–4.1 mg/dL, so this is of importance as when 
scaffold is placed in the system, the levels in the local 
region may be slightly higher than normal, but should 
not increase the overall levels to prevent any 
complications such as cell death, which in turn would 
lead to killing new bone cells. 
Chen et al. [28] and Sweet et al. [29] have studied 
the in vitro analysis of ion release in the SBF solution, 
with regards to cytotoxicity. The cytotoxicity assay 
results indicated that the 100% β-TCP material, which 
is most commonly used, did not have a negative effect 
on altering the Schwann cells in vitro. 
The data from the in vitro portion of this study is in 
agreement with literature. Using the 100% HA and 
100% β-TCP as controls and the two 15%/85% 
HA/β-TCP groups as the experimental groups, the 
results are similar to what was expected. Literature 
presents the bulk or pressed powder properties of these 
two control group materials, but does not present the 
biphasic mixture release for Ca or PO4 in an in vitro 
setting. The results indicate the trend for the two 
biphasic groups, in which the rates of calcium and 
phosphate ion release should fall above the 100% HA 
but below 100% β-TCP. This was the result, which was 
observed when doing a qualitative analysis of the 
results and further identified with the extrapolation of 
data from previous bulk property results. 
Overall, since various chemical formulations can 
lead to different physiochemical properties of these 
extruded materials processed, it is important to 
understand how the tailoring of this important biphasic 
material can impact the long-term outcome of an 
ever-important in vivo clinical trial in the future. 
As the scaffolds can be fabricated from mixing 
various ratios of the bioactive ceramic, HA and β-TCP, 
both of which are biocompatible, resorbable, and can 
facilitate in the regeneration and remodeling of bone at 
defect site, the results are important on how to tailor 
composition. Custom ratios of the materials in scaffolds 
for use in load and non-load bearing models are 
warranted to explore the rate of osseointegration, as the 
release of these ions has the potential to dictate which 
material would be of use in the final scaffold design. 
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